Activité in vitro en 1999/2000 de la levofloxacine vis-à-vis de streptococcus pneumoniae et des streptocoques isolés à l’hôpital et en pratique de ville en France

Geslin, 1997, Rapport d'activité année Centre National de Référence des Pneumocoques Aubry-Damon, 1997, Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: role of an infection control program and changes in aminoglycoside use, Clin Infect Dis, 25, 647, 10.1086/513749 Frémaux, 1999, Le point sur les résistances des pneumocoques en France (1987–1997): impact sur l'antibiothérapie des infections à pneumocoques, Antibiotiques, 2, 93 Doern, 2001, Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999–2000 including a comparison of resistance rates since1994–1995, Antimicrob Agents Chemother, 45, 1721, 10.1128/AAC.45.6.1721-1729.2001 Comité de l'Antibiogramme de la Société Française de Microbiologie. Communiqué 2000–2001 Paris : Société Française de Microbiologie. Weber, 1999, Une enquête de sensibilité à 12 antibiotiques de Streptococcus pneumoniae et Haemophilus influenzae isolés d'infections ORL et respiratoires de l'enfant en médecine de ville, Antibiotiques, 1, 39 Weber, 2000, Etat actuel de la sensibilité à dix antibiotiques des bactéries isolées d'infections non urinaires en médecine de ville : enquête multicentrique 1997–1998, Méd. Mal Infect, 30, 745, 10.1016/S0399-077X(01)80029-9 Davies, 2002, Prevalence of single mutations in topoisomerase type II genes among levofloxacin-susceptible clinical strains of Streptococcus pneumoniae isolated in the United States into1996and1999to2000, Antimicrob Agents Chemother, 46, 119, 10.1128/AAC.46.1.119-124.2002 Drugeon, 2001, Etude épidémiologique de la sensibilité des Streptococcus pneumoniae, des Haemophilus influenzae, et des Moraxella catarrhalis isolées de prélèvements respiratoires en 2000–2001: activité de la télithromycine Schmitz, 1999, Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating from 20 European university hospitals, Eur J Clin Microbiol Infect Dis, 18, 450, 10.1007/s100960050318 Maraki, 2001, Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae isolates from Crete, Int J Antimicrob Agents, 17, 465, 10.1016/S0924-8579(01)00330-2 Felmingham, 2000, Respiratory pathogens: assessing resistance patterns in Europe and potential role of grepafloxacin as treatment of patients with infections caused by these organisms, J Antimicrob Chemother, 45, 1, 10.1093/jac/45.suppl_2.1 Reinert, 2001, Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany fromto1999: results of national surveillance study, J Clin Microbiol, 39, 1187, 10.1128/JCM.39.3.1187-1189.2001 Otéo, 2001, Antimicrobial resistance of Streptococcus pneumoniae isolates inand2000in Madrid, Spain: a multicenter surveillance study, J Antimicrob Chemother, 47, 215, 10.1093/jac/47.2.215 Sham, 2001, Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis, Antimicrob Agents Chemother, 45, 1037, 10.1128/AAC.45.4.1037-1042.2001 Hobban, 2001, A comparative in vitro surveillance study of gemifloxacin activities against 2632 recent streptococcus pneumoniae isolates from across Europe, North America, and South America, Clin Infect Dis, 32, S2, S81 Mathai, 2001, Antibacterial activity of 41 antimicrobial tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I-results from the sentry antimicrobial surveillance program (North America, Diag 1998), Microbiol Infect Dis, 39, 105, 10.1016/S0732-8893(00)00234-0 Ho, 1999, Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong, Antimicrob Agents Chemother, 43, 1310, 10.1128/AAC.43.5.1310 Laurans, 2001, Surveillance de la sensibilité aux antibiotiques des pneumocoques isolés en situation pathogène en France, BEH, 33 Weber, 2001, Streptococcus pneumoniae : absence d'émergence de résistance à la pristinamycine, Path Biol, 49, 840, 10.1016/S0369-8114(01)00255-3